Algorithm for Femoral and Periacetabular Osteotomies in Complex Hip Deformities

Background: Residual acetabular dysplasia of the hip in most patients can be corrected by periacetabular osteotomy. However, some patients have intraarticular abnormalities causing insufficient coverage, containment or congruency after periacetabular osteotomy, or extraarticular abnormalities that limit either acetabular correction or hip motion. For these patients, we believe an additional proximal femoral osteotomy can improve coverage, containment, congruency and/or motion. Purposes: We provide algorithms for (1) identifying patients we believe will benefit from proximal femoral osteotomy, (2) selecting the appropriate osteotomy, and (3) choosing the sequence of these osteotomies. Methods: Anteroposterior, false-profile and functional radiographs and MR can identify most patients we believe will benefit from periacetabular and femoral osteotomies. Recently described techniques, including relative femoral neck lengthening, femoral neck osteotomy and femoral head osteotomy have expanded indications for a combined procedure. Historically performed first, periacetabular osteotomy is now frequently performed following femoral osteotomy. Results: The rate of intertrochanteric osteotomy performed with periacetabular osteotomy has decreased from approximately 10% in the first 500 surgeries to about 2% currently. Among 151 relative neck lengthenings (23 with PAO), 53 femoral neck osteotomies (4 with PAO) and 14 femoral head osteotomies (11 with PAO), eleven complications occurred including osteonecrosis in two and delayed unions in eight. No complication occurred following a combined procedure. Conclusion: Although isolated periacetabular osteotomy can provide sufficient coverage, containment and congruency for most patients with residual hip dysplasia, some may benefit from an additional proximal femoral osteotomy. Knowing the appropriate indications, selection, and sequencing of these osteotomies is critical for enhancing patient outcomes. Level of Evidence: Level V, therapeutic study. See Guidelines for Authors for a complete description of levels of evidenc

In situ pinning with arthroscopic osteoplasty for mild SCFE: A preliminary technical report

There is emerging evidence that even mild slipped capital femoral epiphysis leads to early articular damage. Therefore, we have begun treating patients with mild slips and signs of impingement with in situ pinning and immediate arthroscopic osteoplasty. DESCRIPTION OF TECHNIQUES: Surgery was performed using the fracture table. After in situ pinning and diagnostic arthroscopy, peripheral compartment access was obtained and head-neck osteoplasty was completed

An overview of the planned CCAT software system

CCAT will be a 25m diameter sub-millimeter telescope capable of operating in the 0.2 to 2.1mm wavelength range. It will be located at an altitude of 5600m on Cerro Chajnantor in northern Chile near the ALMA site. The anticipated first generation instruments include large format (60,000 pixel) kinetic inductance detector (KID) cameras, a large format heterodyne array and a direct detection multi-object spectrometer. The paper describes the architecture of the CCAT software and the development strategy.Comment: 17 pages, 6 figures, to appear in Software and Cyberinfrastructure for Astronomy III, Chiozzi & Radziwill (eds), Proc. SPIE 9152, paper ID 9152-10

Dynamical simulation of transport in one-dimensional quantum wires

Transport of single-channel spinless interacting fermions (Luttinger liquid) through a barrier has been studied by numerically exact quantum Monte Carlo methods. A novel stochastic integration over the real-time paths allows for direct computation of nonequilibrium conductance and noise properties. We have examined the low-temperature scaling of the conductance in the crossover region between a very weak and an almost insulating barrier.Comment: REVTex, 4 pages, 2 uuencoded figures (submitted to Phys. Rev. Lett.

Introduction:Structuralists of the world unite

Supplementary Table S3: Temporally significant metabolites from DMSO treatment as determined by t-test, p<0.05. These tables include all metabolites that were significantly changing from DMSO control treatment between A) 0.5 – 1 h (72 metabolites), B) 0.5 – 4 h (76 metabolites), and C) 1 - 4 h (25 metabolites). Metabolites were included in this table if annotated with either KEGGID or HMDBID. Tables include compound name, KEGGID (if applicable), HMDBID (if applicable), and p-value from t-test (methods described above)